Amyotrophic lateral sclerosis Trials in Leuven, Belgium
Conditions / Amyotrophic lateral sclerosis / Leuven, Belgium
Clinical trials for Amyotrophic lateral sclerosis investigate a range of treatment strategies and patient populations.
39 total trials for this combination
Showing top 10 of 39 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT01622088 | Phase 3 Extension Study of Dexpramipexole in ALS | TERMINATED | PHASE3 |
| NCT04944784 | A Study to Evaluate the Efficacy and Safety of Reldesemtiv in Patients With Amyotrophic Lateral Sclerosis (ALS) | TERMINATED | PHASE3 |
| NCT05237284 | Phase 2 Study for SAR443820 in Participants With Amyotrophic Lateral Sclerosis (ALS) | TERMINATED | PHASE2 |
| NCT02623699 | An Efficacy, Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of BIIB067 (Tofersen) in Adults With Inherited Amyotrophic Lateral Sclerosis (ALS) | COMPLETED | PHASE3 |
| NCT02496767 | Ventilatory Investigation of Tirasemtiv and Assessment of Longitudinal Indices After Treatment for a Year | COMPLETED | PHASE3 |
| NCT04248465 | An Efficacy and Safety Study of Ravulizumab in ALS Participants | TERMINATED | PHASE3 |
| NCT05021536 | Phase III Trial of AMX0035 for Amyotrophic Lateral Sclerosis Treatment | ACTIVE_NOT_RECRUITING | PHASE3 |
| NCT01281189 | Phase 3 Study of Dexpramipexole in ALS | COMPLETED | PHASE3 |
| NCT03505021 | Effects of Oral Levosimendan (ODM-109) on Respiratory Function in Patients With ALS | COMPLETED | PHASE3 |
| NCT03948178 | Effects of Oral Levosimendan on Respiratory Function in Patients With Amyotrophic Lateral Sclerosis (ALS): Open-Label Extension | TERMINATED | PHASE3 |